Overview
This workshop on cell and gene therapies aims to meet the needs of the developers of advanced therapies to discuss a range of topics that will help them make more informed decisions on regulatory strategies and evidence packages - as well as market access challenges - which are key topics for cell and gene therapy developers.
It will feature speakers from regulators, payers, patients, industry and academic organisations. Participants will benefit from the direct interaction with these stakeholders as a part of the main programme and during the networking events.
Program Committee
-
Alexander Natz, JD Secretary General
European Confederation of Pharmaceutical Entrepreneurs, Belgium -
Maren von Fritschen, PharmD Head EU Regulatory Policy
Moderna, Netherlands -
Inka Heikkinen, MBA, MSc Regulatory Policy Lead
Lundbeck, Denmark -
Thomas Bols, MA Head of Government affairs and Patient Advocacy, EMEA & APAC
PTC Therapeutics, Inc., Switzerland
Have an account?